Stockreport

Cancer Concerns Are a New Worry for Gene Therapy. BioMarin Stock Is Falling. [Barron's]

BioMarin Pharmaceutical Inc.  (BMRN) 
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.biomarin.com
PDF The company’s stock (ticker: BMRN) fell 7.5% Tuesday morning, to $78.60, on news that the U.S. Food and Drug Administration had placed a hold on the clinical trial of a [Read more]